New Jersey adopted PMP Aware to create a centralized database to track opioid prescriptions. Using this technology is one of the most immediate things we can do to help fight the opioid crisis. Regularly using this website will also earn you Improvement Activities points for MIPS.
However, we’ve noticed a lot of confusion about how and when the Prescription Drug Monitoring Website should be used. To help clear this up, we did a little bit of research and found the information below:
“Pursuant to N.J.A.C.13:45A-35.9, a prescriber or the prescriber’s delegate shall access prescription monitoring information for a new or current patient consistent with the following:
- The first time the practitioner prescribes a Schedule II controlled dangerous substance to a new or current patient for acute or chronic pain; and
- On a quarterly basis (every three months) during the period of time, a current patient continues to receive a prescription for a Schedule II controlled dangerous substance for acute or chronic pain.
Before issuing a prescription or dispensing a prescribed drug, registered prescribers are able to access the NJPMP website and request the CDS and HGH prescription history of the patient. The users must certify that they are seeking information for a specific, new or current patient.
Patient information in the NJPMP is intended to supplement an evaluation of a patient, confirm a patient’s drug history, and document compliance with a therapeutic regimen.
When prescribers identify a patient as potentially having an issue of concern regarding drug use, they are encouraged to help the patient locate assistance and take any other action the prescriber deems appropriate.”
If you’d like more information about Prescription Drug Monitoring, you can find it here.
If you prescribe narcotics and are not currently registered for NJPMP, we strongly recommend that you sign up right now.